If market segmentation is about finding out who people really are, why are we doing so many costly projects?
Doesn’t it make sense that distinct personality types will respond in similar ways to different diseases as patients, or HCPs and other groups?
We believe the answer is yes, and we’ll show you how some pharma companies have saved time and money and gained valuable insight by using our standardized segmentation approach.
We’ll also cover a choice modeling method for developing customized segmentations based on what is really important to your customers.
Don’t start a segmentation project until you have seen this webinar.Request A Webinar